[Clinical characteristics and risk factors of cardiovascular disease in patients with elderly-onset rheumatoid arthritis: A large cross-sectional clinical study].

OBJECTIVE

To investigate the clinical characteristics of patients with elderly-onset rheumatoid arthritis (EORA), and the risk factors of EORA complicated with cardiovascular disease (CVD).

METHODS

A cross-sectional study was conducted in Peking University People's Hospital from July 2009 to December 2014 and 1 116 patients were recruited. The patients' characteristics and CVD, including ischemic heart disease, cerebral and peripheral vascular disease, were recorded. The patients were divided into EORA group (=212) and younger-onset rheumatoid arthritis (YORA) group (=904) according to the age of onset ≥60 years and < 60 years. Then, the differences between the groups were analyzed by Student's test, Mann-Whitney test or test, and risk influencing CVD were analyzed using Logistic regression.

RESULTS

There was no significant difference in the disease activity between the EORA and YORA groups. The proportion of male, pulmonary interstitial disease (ILD), and numbers of deformity joint count (DJC) were significantly higher in the EORA group compared with the YORA group [32.1% . 18.5%, =19.11, < 0.001; 23.6% . 13.6%, =16.50, < 0.001; 6 (2, 12) . 3 (2, 7), =-3.60, < 0.001], while the prevalence of Sjögren's syndrome was lower than that of the YORA group (13.5% . 5.2%, =11.29, =0.001). Moreover, there were lower prevalences in the patients treated with disease-modifying antirheumatic drugs (DMARDs) in EORA group (35.4%) than in YORA group (26.7%) (=6.43, =0.011), especially in methotrexate (MTX), hydroxychloroquine (HCQ) and sulfasalazine (SSZ). In addition, the patients with EORA had a higher prevalence of CVD (27.8%) than the YORA group (11.6%, =40.46, < 0.001), accompanied with higher prevalence of smoking, hypertension, and hyperlipidemia. Multivariate Logistic regression analysis showed that elder age (=1.10, 95%: 1.00-1.20), DJC (=3.17, 95%: 1.04-9.68), rheumatoid nodules (=3.56, 95%: 1.03-12.23), hypertension (=2.37, 95%: 1.09-5.13) and hyperlipidemia (=8.85, 95%: 2.50-31.27) were independent risk factors, while HCQ (=0.22, 95%: 0.07-0.70) and MTX (=0.32, 95%: 0.14-0.73) were protective factors of EORA complicated with CVD.

CONCLUSION

Compared with YORA, patients with EORA have higher ratio of male, ILD and DJC, which may be attributed to inappropriate therapies. EORA is more likely to be complicated with CVD than YORA. Elder age, DJC, rheumatoid nodules, hypertension, and hyperlipidemia are independent risk factors, while HCQ and MTX are protective factors of EORA complicated with CVD.